Oramed Pharmaceuticals, Inc. (ORMP)
5.29
+0.08
(+1.54%)
USD |
NASDAQ |
Aug 26, 13:37
Oramed Pharmaceuticals Market Cap : 218.55M for Aug. 26, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 25, 2026 | 215.25M |
| August 24, 2026 | 199.13M |
| August 21, 2026 | 198.72M |
| August 20, 2026 | 197.90M |
| August 19, 2026 | 197.90M |
| August 18, 2026 | 197.48M |
| August 17, 2026 | 188.81M |
| August 14, 2026 | 185.09M |
| August 13, 2026 | 180.96M |
| August 12, 2026 | 176.41M |
| August 11, 2026 | 175.59M |
| August 10, 2026 | 173.52M |
| August 07, 2026 | 177.65M |
| August 06, 2026 | 177.65M |
| August 05, 2026 | 176.80M |
| August 04, 2026 | 182.53M |
| August 03, 2026 | 179.67M |
| July 31, 2026 | 166.57M |
| July 30, 2026 | 168.62M |
| July 29, 2026 | 162.48M |
| July 28, 2026 | 170.66M |
| July 27, 2026 | 170.25M |
| July 24, 2026 | 164.93M |
| July 23, 2026 | 170.25M |
| July 22, 2026 | 164.52M |
| Date | Value |
|---|---|
| July 21, 2026 | 164.52M |
| July 20, 2026 | 167.80M |
| July 17, 2026 | 164.93M |
| July 16, 2026 | 165.75M |
| July 15, 2026 | 166.16M |
| July 14, 2026 | 163.70M |
| July 13, 2026 | 161.86M |
| July 10, 2026 | 165.34M |
| July 09, 2026 | 171.07M |
| July 08, 2026 | 175.57M |
| July 07, 2026 | 175.98M |
| July 06, 2026 | 187.03M |
| July 02, 2026 | 188.26M |
| July 01, 2026 | 188.67M |
| June 30, 2026 | 196.85M |
| June 29, 2026 | 189.90M |
| June 26, 2026 | 191.12M |
| June 25, 2026 | 204.63M |
| June 24, 2026 | 175.98M |
| June 23, 2026 | 170.66M |
| June 22, 2026 | 164.11M |
| June 18, 2026 | 158.79M |
| June 17, 2026 | 155.11M |
| June 16, 2026 | 154.29M |
| June 15, 2026 | 157.16M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 1.128T |
| Pfizer Inc. | 161.97B |
| Yarrow Bioscience, Inc. | 27.37M |
| Liquidia Corp. | 6.420B |
| NRX Pharmaceuticals, Inc. | 148.03M |
Market Cap Related Metrics
| PE Ratio | 1.287 |
| Price to Book Value | 0.6884 |
| Price | 5.29 |
| Earnings Yield | 77.70% |
| Normalized PE Ratio | 5.046 |